NanoViricides (NNVC) Balance Sheet: Assets & Liabilities

NanoViricides (NNVC) Balance Sheet

As of Jun 30, 2026 (end of fiscal 2026), NanoViricides reported total assets of $9.87T and total liabilities of $1.19T. Shareholders' equity was $8.68T, up 115501247.1% from $7.52M a year earlier. Total debt stood at $0.00 against $2.79T in cash and short-term investments, a net cash position of $2.79T. That puts debt-to-equity at 0.00, compared with 0.00 a year earlier.

NanoViricides Balance Sheet Analysis

Values in trillions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for NanoViricides, Inc. (NNVC) - Annual data in trillions USD
Breakdown	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Jun 2026	Jun 2025	Jun 2024	Jun 2023	Jun 2022	Jun 2021	Jun 2020	Jun 2019	Jun 2018	Jun 2017
Current Assets
Cash and Cash Equivalents	2.79	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Cash & Short-Term Investments	2.79	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Accounts Receivable	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Inventory	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Current Assets	0.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Current Assets	3.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Non-Current Assets
Property, Plant & Equipment (Net)	6.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Intangible Assets	0.31	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Non-Current Assets	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Non-Current Assets	6.71	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Assets	9.87	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities
Accounts Payable	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Short-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Accrued Liabilities	-	0.00	0.00	0.00	0.00	0.00	-	-	-	-
Deferred Revenue	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Current Liabilities	1.19	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Current Liabilities	1.19	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Non-Current Liabilities
Long-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Non-Current Liabilities	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Non-Current Liabilities	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Liabilities	1.19	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Stockholders' Equity
Common Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Retained Earnings	-157.06	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Additional Paid-in Capital	165.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Shares Outstanding	-	0.00	0.00	0.00	0.00	-	-	-	-	-
Total Stockholders' Equity	8.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Liabilities & Equity	9.87	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About NanoViricides Balance Sheet

How much debt does NanoViricides have?

NanoViricides had total debt of $0.00 as of Jun 30, 2026, against $2.79T in cash and short-term investments. Its debt-to-equity ratio was 0.00. Total debt was $0.00 a year earlier.

What are NanoViricides's total assets?

NanoViricides reported total assets of $9.87T as of Jun 30, 2026, up 111893813.1% from $8.82M a year earlier. Total liabilities were $1.19T.

What is NanoViricides's shareholders' equity?

NanoViricides's shareholders' equity was $8.68T as of Jun 30, 2026.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition